Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Development and validation of a Deep Learning (DL)-based screening tool for ‘Plus disease’ detection on retinal images captured through a tele-ophthalmology platform for Retinopathy of prematurity (ROP) in India
Author Affiliations & Notes
  • Anand Vinekar
    Pediatric Retina, Narayana Nethralaya, Bangalore, Karnataka, India
  • Vincent Yong Wei Jie
    Remidio Innovative Solutions Pvt Ltd, Bangalore, India
    School of Computer Science and Engineering, Nanyang Technical University, Singapore
  • Florian M Savoy
    Remidio Innovative Solutions Pvt Ltd, Bangalore, India
  • Divya Rao Parthasarathy
    Remidio Innovative Solutions Pvt Ltd, Bangalore, India
  • Footnotes
    Commercial Relationships   Anand Vinekar, None; Vincent Yong Wei Jie, Remidio Innovative Solutions Pvt Ltd (E); Florian Savoy, Remidio Innovative Solutions Pvt Ltd (E); Divya Rao Parthasarathy, Remidio Innovative Solutions Pvt Ltd (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3267. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anand Vinekar, Vincent Yong Wei Jie, Florian M Savoy, Divya Rao Parthasarathy; Development and validation of a Deep Learning (DL)-based screening tool for ‘Plus disease’ detection on retinal images captured through a tele-ophthalmology platform for Retinopathy of prematurity (ROP) in India. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3267.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Plus disease denotes a severe vascular abnormality in cases of ROP, which may portend to requiring treatment to prevent blindness but its assessment is subjective. Bringing in Artificial Intelligence (AI) automation can not only improve diagnostic consistencies but can also help scale up ROP screening services to remote and underserved regions of the world. We developed and assessed the performance of an AI algorithm to automatically detect the presence of Plus disease in retinal images of premature babies.

Methods : We trained a deep learning (DL) algorithm with 42,641 disc and macula centered images from a tele-ROP screening program in India. The model was trained to indicate the presence of Plus in the images. Since the dataset contained 0.5% of Plus images, it was trained using metric learning, a technique improving DL performance under datasets with strong class imbalance. Pre-Plus images were not presented to the AI during training. The algorithm was tested on two distinct datasets. Test set A consists of 10,976 images, with 169 pre-plus, 70 plus images and rest no plus images. Test set B consists of 108 images, with 39 pre-Plus, 45 Plus images and rest no plus images. The reference standard for training and test sets was the interpretation of ROP specialists.

Results : The sensitivity on test set A was 95.7% (95% CI: 88.0% to 99.1%), with 3 Plus images being misclassified. Specificity with pre-plus as non-referable was 99.6% (95% CI: 99.4% to 99.7%), and 99.9% (95% CI: 99.8% to 100%) if pre-plus images were excluded. The sensitivity on test set B was 97.8% (95% CI: 88.2% to 99.9%) with one Plus image being misclassified. The specificity was 68.3% (95% CI: 55.3% to 79.4%) with pre-plus, and 100% (95% CI: 85.8% to 100%) without.

Conclusions : The DL tool for ROP Plus detection has excellent sensitivity in picking up Plus disease and thus can potentially be used as a triaging tool for infants with ROP requiring immediate treatment. A prospective clinical validation in a real-world setting is under consideration.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×